| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2093830 | POLR2J3 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 7 | - |
PV=1 FDR=1 FC=-0.102 |
|
| 2093831 | POLR2J3 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 7 | - |
PV=1 FDR=1 FC=0.003 |
|
| 2093832 | C17orf49 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 17 | - |
PV=1 FDR=1 FC=0.004 |
|
| 2093833 | GFI1B | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 9 | - |
PV=1 FDR=1 FC=0.007 |
